Delivery Order SPE2DB20D2104-SPE2DB26FMBJM
- Not listed
- The Defense Logistics Agency awarded a $4,547.56 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Xhance 93 microgram nasal spray (16 milliliters). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,855.22 to AmerisourceBergen Drug Corp for XHANCE 93 microgram nasal spray (16 milliliters) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,134.11 to supply Xhance 93 MCG nasal spray (16 mL units) with an ultimate completion date of September 18, 2025. This non-competitive delivery order utilizes firm fixed pricing and was awarded on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a $1,351.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XHANCE 93 mcg nasal spray (16 ml), with an ultimate completion date of September 23, 2025. This is a non-set-aside competitively awarded contract supporting federal medical procurement needs. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $1,212.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xhance 93 mcg nasal spray (16 mL). This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,668.46 to AmerisourceBergen Drug Corp for XHANCE 93 MCG Nasal Spray (16ML) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical supplier within the federal medical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,463.62 order is for Xhance 93 mcg nasal spray and has a completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,183.44 firm fixed-price contract is for the supply of XHANCE 93 MCG Nasal Spray 16ML, with a completion date of November 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency awarded a $337,630 firm fixed price delivery order to AmerisourceBergen Drug Corporation for Xhance 93 mcg nasal spray. As part of its mission to support military readiness, the DLA procures pharmaceuticals and medical supplies through Prime Vendor contracts like the one held by AmerisourceBergen. This delivery order calls for 16ml bottles of the nasal spray to treat nasal polyps and is being fulfilled from AmerisourceBergen's facility in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $5,781.06 firm fixed price delivery order is for the supply of the pharmaceutical product XHANCE 93 MCG Nasal Spray 16ML. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) from DLA with a potential value of $999,999,999.00 and a performance period...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMBJMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,615.59 to AmerisourceBergen Drug Corp for Xhance 93 microgram nasal spray (16 milliliters) on October 30, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to military healthcare programs worldwide. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Xhance nasal spray—a prescription medication for nasal polyps—exemplifies the routine pharmaceutical procurement conducted under this expansive contract framework, demonstrating AmerisourceBergen's critical role in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 10/30/25 |